bpc-157 for ulcerative colitis JPP No 5/2013 article 09 KPV Peptide and Ulcerative Colitis

These findings collectively point to Epitalon as a functional telomerase modulator, capable of extending telomeres, delaying replicative senescence, and maintaining cellular health across multiple biological systems

Systemic GHK-Cu does different things from locally applied GHK-Cu, and the dose-response curves are different

Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data

It activates the HGF/c-Met receptor pathway in the brain, promoting the formation of new synaptic connections (synaptogenesis)